Tamir Biotechnology Inc. (GM) Stock Price - ACEL

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$49.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Tamir Biotechnology Inc. (GM) ACEL Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 0.05 - - - 0.05 02:05:05
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Tamir Biotechnology Inc. (GM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.37M 47.32M $ -12.32M - - -
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
23.1k 0.05% $ - 0.00% - -

more financials information »

Tamir Biotechnology Inc. (GM) News

Real-Time news about Tamir Biotechnology Inc. (GM) (Other OTC): 0 recent articles

Historical ACEL Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.000.000.000.0000000--
1 Month0.000.000.000.0000000--
3 Months0.000.000.000.0000000--
6 Months0.000.000.000.0000000--
1 Year0.000.000.000.0000000--
3 Years0.000.000.000.0000000--
5 Years0.090.090.000.000001M34k-0.04-44.44%

Tamir Biotechnology Inc. (GM) Description

Tamir Biotechnology, Inc. (formerly Alfacell Corporation) is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of therapies for cancer, viral, and other life-threatening diseases. Currently, Tamir is conducting a Phase II clinical trial with the addition of RANPIRNASE (ONCONASE) to PEMETREXED plus CARBOPLATIN in patients with non-squamous, non-small cell lung cancer (NSCLC).
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161211 04:12:48